What is the Normal Dose of Mounjaro for Weight Loss?

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Mounjaro, works by activating both GLP-1 and GIP receptors in the brain to reduce appetite and improve metabolic function. Understanding how dosing progresses helps patients set realistic expectations for their weight loss journey. PlexusDx offers compounded tirzepatide injections that follow clinical dosing guidelines starting at $289 per month.

How Tirzepatide Dosing Starts for Weight Loss

The standard tirzepatide dosing protocol begins at 2.5 milligrams injected subcutaneously once per week. This introductory dose allows your body to adapt to the medication while minimizing gastrointestinal side effects that some patients experience during early treatment. Most patients tolerate this starting point well, though your prescriber may adjust timing based on your individual response.

Weekly injections provide consistent exposure to the dual GLP-1 and GIP receptor activation, which distinguishes tirzepatide from single-receptor GLP-1 medications. The 2.5 mg baseline is the lowest therapeutic dose and typically produces measurable appetite suppression within the first two weeks of treatment. Your healthcare provider will monitor your response during this phase to determine readiness for dose escalation.

The Tirzepatide Dose Escalation Protocol

After four weeks at the 2.5 mg dose, your prescriber typically increases the weekly injection to 5 mg if you tolerate the medication well. This four-week interval between increases allows your body time to adapt and your provider to assess weight loss progress and side effect management. Subsequent increases occur every four weeks, advancing by 2.5 mg increments: from 5 mg to 7.5 mg, then to 10 mg, and finally to 15 mg.

The stepwise escalation approach reflects clinical trial design that demonstrated sustained weight loss at each dose tier without requiring rapid increases. Most patients achieve meaningful weight reduction at intermediate doses between 7.5 and 10 mg weekly, though some benefit from reaching the 15 mg maintenance dose. Your individual genetics, metabolism, and weight loss response determine whether you need to progress to higher doses or maintain effectiveness at a lower level.

Maintenance Doses and Long-Term Tirzepatide Use

The maximum approved tirzepatide dose for weight loss is 15 mg injected once weekly, which serves as the long-term maintenance dose for most patients who require it. Clinical evidence shows that patients typically remain on their effective maintenance dose for extended periods, with sustained weight loss observed over 12 months and beyond. Your prescriber may recommend staying at a lower dose like 10 mg if you achieve your weight loss goals and tolerate the medication well.

Maintenance dosing philosophy focuses on finding the minimum effective dose that produces your desired weight loss while minimizing side effects. PlexusDx ensures your dose can increase as needed without your monthly price changing—your investment remains $289 per month whether you inject 2.5 mg or 15 mg weekly. This pricing structure removes financial barriers to dose optimization based on your clinical needs.

Personalized Dosing Through Genetic Insights

Individual genetic variations in GLP-1 receptor function and metabolic pathways influence how effectively tirzepatide works for your weight loss. PlexusDx Precision Peptide Genetic Test examines key variants including GLP1R rs6923761 and GIPR rs1800437, which affect how your body responds to dual receptor activation. Patients with specific genetic profiles may reach their weight loss goals at lower doses, while others benefit from advancing to higher maintenance doses.

The test maps 14 metabolic pathways and 49 peptide interactions to reveal your personalized response pattern to tirzepatide therapy. Adding the Precision Peptide Genetic Test ($99 after your first month) to your PlexusDx treatment plan helps your prescriber make informed decisions about your optimal dose trajectory and medication selection. This genetic guidance transforms tirzepatide dosing from a one-size-fits-all protocol into a precision-medicine approach tailored to your biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of tirzepatide for weight loss?

The standard starting dose is 2.5 mg injected subcutaneously once per week. PlexusDx compounded tirzepatide injections begin at this dose and follow evidence-based escalation protocols, with your monthly price remaining flat at $289 regardless of which dose you progress to.

How quickly does tirzepatide dosing increase?

Tirzepatide dosing increases by 2.5 mg increments every four weeks, allowing your body to adapt between increases. Most patients progress through doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, and potentially 15 mg over a 16-week period, though your prescriber may adjust timing based on your individual tolerance and response.

Why doesn't my PlexusDx price change as my dose increases?

PlexusDx uses a flat-rate pricing model where your dose may increase but your price won't—remaining at $289 monthly for compounded tirzepatide injection. This removes financial hesitation about dose optimization and ensures your therapy can scale with your clinical needs without added cost.

Can I stay on a lower tirzepatide dose if it works for me?

Yes, many patients achieve their weight loss goals at intermediate doses like 7.5 mg or 10 mg and successfully maintain results without advancing to 15 mg. Your prescriber will work with you to identify your optimal effective dose, balancing weight loss outcomes with your side effect tolerance and health goals.

How does the Precision Peptide Genetic Test help with tirzepatide dosing?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.